Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

The original article was published in BMC Cancer 2015 15:941

Unfortunately, the original version of this article [1] contained a mistake. The word ‘survivin’ in the title was incorrectly included as ‘surviving’. The title has been corrected above and in the original article.

Reference

  1. 1.

    Gravina G, Mancini A, Sanita P, Vitale F, Marampon F, Ventura L. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC Cancer. 2015;15:941.

Download references

Author information

Correspondence to Claudio Festuccia.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-015-1936-z.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark